LARS Antikörper (AA 614-892) (FITC)
-
- Target Alle LARS Antikörper anzeigen
- LARS (Leucyl-tRNA Synthetase (LARS))
-
Bindungsspezifität
- AA 614-892
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LARS Antikörper ist konjugiert mit FITC
- Applikation
- Bitte anfragen
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Leucine--tRNA ligase, cytoplasmic protein (614-892AA)
- Isotyp
- IgG
- Top Product
- Discover our top product LARS Primärantikörper
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- LARS (Leucyl-tRNA Synthetase (LARS))
- Andere Bezeichnung
- LARS (LARS Produkte)
- Synonyme
- HSPC192 antikoerper, LARS1 antikoerper, LEURS antikoerper, LEUS antikoerper, LRS antikoerper, PIG44 antikoerper, RNTLS antikoerper, hr025Cl antikoerper, CG7479 antikoerper, Dmel\\CG7479 antikoerper, LeuRS antikoerper, F21M12.1 antikoerper, F21M12_1 antikoerper, BA4991 antikoerper, DDBDRAFT_0183834 antikoerper, DDBDRAFT_0231251 antikoerper, DDB_0183834 antikoerper, DDB_0231251 antikoerper, 2310045K21Rik antikoerper, 3110009L02Rik antikoerper, AW536573 antikoerper, mKIAA1352 antikoerper, leucyl-tRNA synthetase antikoerper, Leucyl-tRNA synthetase, mitochondrial antikoerper, ATP binding/leucine-tRNA ligases/aminoacyl-tRNA ligase antikoerper, leucine--tRNA ligase antikoerper, leucyl-tRNA synthetase LeuS antikoerper, leucyl-tRNA ligase antikoerper, leucine-tRNA ligase antikoerper, LARS antikoerper, LeuRS-m antikoerper, AT1G09620 antikoerper, leuS antikoerper, APH_RS02290 antikoerper, mleuS antikoerper, Lars antikoerper
- Hintergrund
-
Background: Catalyzes the specific attachment of an amino acid to its cognate tRNA in a two step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. Exhibits a post-transfer editing activity to hydrolyze mischarged tRNAs.
Aliases: cytoplasmic antibody, Cytoplasmic leucyl tRNA synthetase antibody, Cytosolic leucyl tRNA synthetase antibody, FLJ10595 antibody, FLJ21788 antibody, hr025Cl antibody, HSPC 192 antibody, HSPC192 antibody, KIAA1352 antibody, LARS 1 antibody, Lars antibody, LARS1 antibody, Leucine translase antibody, Leucine tRNA ligase antibody, Leucine--tRNA ligase antibody, Leucyl tRNA synthetase cytoplasmic antibody, Leucyl-tRNA synthetase antibody, LeuRS antibody, LEUS antibody, LRS antibody, PIG 44 antibody, PIG44 antibody, Proliferation inducing gene 44 antibody, RNTLS antibody, SYLC_HUMAN antibody
- UniProt
- Q9P2J5
- Pathways
- EGFR Signaling Pathway
-